GlobalGov › United States › Award

OSIVAX won OSIVAX - CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A VACCINE FOR IMMEDIATE PROTECTION AGAINST from the Government of United States

the Government of United States · United States government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$19.5M
Award Value
July 25, 2025
Award Date
Awarded
Status

Award Overview

OSIVAX was awarded OSIVAX - CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A VACCINE FOR IMMEDIATE PROTECTION AGAINST by the Government of United States in United States, tracked by GlobalGov. The award is valued at $19.5M. It was awarded on July 25, 2025. Classification: NAICS 541714, PSC AN11. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeOSIVAX
Awarding agencythe Government of United States
CountryUnited States
Award value$19.5M
Award dateJuly 25, 2025
NAICS541714
PSCAN11
Place of performanceUnited States
Last verifiedSeptember 1, 2026

Source: U.S. Government (USAspending.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

United States market overview →Browse open opportunities →

Track every United States contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required